Physician

David Karim Rabady, M.D.

According to 2025 Medicare claims, David Rabady, M.D. (NPI: 1871754846) practices ophthalmology in the Albany-Schenectady-Troy, NY market, with the plurality of this provider's patient population coming from Rensselaer, NY. This provider's primary affiliated billing organization is ALBANY TROY CATARACT & LASER ASSOCIATES (NPI: 1336389295; TIN: 263812418) and primary practice location at 12065-2933.

Rabady's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,183 traditional Medicare patients, billed 98,394 HCPCS/CPT codes, and received $3,553,578 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 785 prescription claims across 399 beneficiaries totaling $48,969 in drug costs, led by Difluprednate (Difluprednate). Open Payments data shows 39 records totaling $1,251. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,250,171 to $3,553,578. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $68,347 and ending at $48,969. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	963	8,644	$1,250,171
2016	992	11,908	$1,923,796
2017	966	11,951	$2,374,530
2018	983	15,817	$2,859,920
2019	988	17,191	$3,139,466
2020	945	14,846	$3,115,028
2021	906	12,829	$2,725,442
2022	1,088	31,604	$3,219,254
2023	1,182	89,002	$3,861,529
2024	1,183	98,394	$3,553,578

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	301	718	$68,347
2016	218	508	$49,331
2017	222	591	$44,023
2018	251	569	$45,774
2019	262	609	$68,179
2020	260	575	$78,108
2021	286	655	$87,042
2022	318	700	$71,386
2023	385	827	$85,625
2024	399	785	$48,969

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	454	638	$109
92014	Established patient complete exam of visual system	1,105	1,508	$84
67028	Injection of drug into eye	301	1,943	$81
92134	Imaging of retina	635	1,795	$28
92250	Photography of the retina	395	420	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Difluprednate	Difluprednate	46	1,086	$4,835
Simbrinza	Brinzolamide/Brimonidine Tart	20	1,177	$4,032
Cyclosporine	Cyclosporine	11	450	$3,785
Prednisolone Acetate	Prednisolone Acetate	95	2,550	$2,942
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	225	4,612	$2,938

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$1,251	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Karim Rabady, M.D.?

Tedicare shows public-source Medicare data for David Karim Rabady, M.D. (NPI 1871754846), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Karim Rabady, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Karim Rabady, M.D.?

David Karim Rabady, M.D. is linked to ALBANY TROY CATARACT & LASER ASSOCIATES (billing NPI 1336389295) in the available physician profile data.

Does David Karim Rabady, M.D. have Open Payments data?

David Karim Rabady, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.